IGC IGC Pharma, Inc.

AMEX
$0.20

IGC Pharma, Inc. (IGC) is expected to report earnings on February 5, 2027, before the market open. The consensus earnings estimate is a loss of $0.02 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +5.4% since its last earnings release on November 6, 2026.

IGC Pharma Reported In-line with Estimates
Monday, November 9, 2026 · 8:00 AM ET
Earnings Date
4th Quarter, Dec 2026
Feb 5
Friday · Before Open
Earnings Whisper
-
vs ($0.02)
Rev est $280K
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $0.20

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About IGC Pharma, Inc.

India Globalization Capital Inc is engaged in acquiring, incubating, financing and growing companies in multiple industries & locations. The Company trades iron ore & lease construction equipment in India; and operates iron ore plants in China.

Sector

Healthcare

Industry

Drug Manufacturers/Other

Charts powered in part by Lightweight Charts™ by TradingView.